Benefits and disadvantages of combination therapy with imeglimin and metformin in patients with type 2 diabetes

Authors

Institutions

Publication Details

Journal
Expert Opinion on Pharmacotherapy
Published
2025-03-29
DOI
https://doi.org/10.1080/14656566.2025.2486354
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Benefits and disadvantages of combination therapy with imeglimin and metformin in patients with type 2 diabetes

Ito H, Michiko Togane, Suzuko Matsumoto, Emiko Tsugami et al.
1 links
Expert Opinion on Pharmacotherapy
Diabetes Treatment and Management
article

Benefits and disadvantages of combination therapy with imeglimin and metformin in patients with type 2 diabetes

Ito H, Michiko Togane, Suzuko Matsumoto, Emiko Tsugami, I Chiaki, Shinichi Antoku, Tomoko Yamasaki, Shun Miura, Hideyuki Inoue, Toshiko Mori
article en

Abstract

No abstract available for this paper.
Expert Opinion on PharmacotherapyVol. 26(6)
Edogawa Hospital (JP)
Zero hunger
Openalex Percentile: Top 92%
Diabetes Treatment and Management
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.